BioPorto A/S
BIOPOR
Rank in Stocks
#22680
BioPorto A/S is a Danish in-vitro diagnostics specialist, supplying biomarker... BioPorto A/S is a Danish in-vitro diagnostics specialist, supplying biomarker tests, research tools, and antibodies to medical professionals and scientists worldwide, with operations across Europe, North America, and Asia. Among its offerings is the neutrophil gelatinase-associated lipocalin (NGAL) test, a precise quantitative particle-enhanced turbidimetric immunoassay designed for use on automated chemistry analyzers. The company further provides monoclonal antibodies essential for scientific, pharmaceutical, and clinical investigations. Additionally, BioPorto produces enzyme-linked immunosorbent assay (ELISA) kits and a versatile rapid assay device tailored for custom lateral flow assay development. Established in 1917, the company is headquartered in Hellerup, Denmark.
Share Price
$0.16512379
Last synced: 2026-10-16
Market Cap
$81.75M
Change (1 day)
-0.95%
Change (1 year)
-42.67%
Country
DK
Trade BioPorto A/S (BIOPOR)
Category
Healthcare
Market Capitalization of BioPorto A/S(BIOPOR)
Market Cap: $81.75M
As of October 2026 BioPorto A/S has a market cap of $81.75M. This makes BioPorto A/S the world's 22680th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of BioPorto A/S from 2019 to 2026
BIOPOR compared with Top 5 Most Popular stocks
